Aarti Drugs

L37060MH1984PLC055433 · ISIN INE767A01016 · 4 filings, FY 2022-23 to FY 2025-26 · standalone basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

reporting_boundary_changed. Reporting boundary changed across years: FY 2022-23 Standalone basis, FY 2023-24 Standalone, FY 2024-25 Standalone, FY 2025-26 Standalone. Year-on-year figures cover different entities.

CategoryFY 2022-23FY 2023-24FY 2024-25FY 2025-26
Plastics including packaging not filed174.85not filednot filed
E-waste not filed36,164.04not filednot filed
Hazardous waste not filed0not filednot filed
Other waste 4,354.684,110.79not filednot filed
Total reclaimed 4,354.6840,449.6800

Recycled or reused input material

Share of total material by value, per material line as the company named it. Each line carries its own denominator, so they are never summed or averaged.

Input material, as filedFY 2022-23FY 2023-24FY 2024-25FY 2025-26
In our production process, we priorities sustainability by recycling solvents and selected raw materials. We recycle around 43-45% solvents and selected raw material. not filed43.0%not filednot filed

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
21001 API 89.00%
21001 Speciality Chemicals 8.00%
21001 Intermediates & others 3.00%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2022-23 Standalone basis 2023-06-30 25,00,00,00,000
FY 2023-24 Standalone 2024-04-30 22,66,91,13,910
FY 2024-25 Standalone 2025-05-31 21,73,65,48,833
FY 2025-26 Standalone 2026-02-28 22,60,38,50,028.39

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error